News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 198105

Monday, 12/01/2014 8:33:26 AM

Monday, December 01, 2014 8:33:26 AM

Post# of 347009
MDSC's increase is bad

PS Targeting such as with Bavituximab decreases MDSC's

MDSC's decrease is good

Dmitry Gabrilovich is becoming the most referenced expert on MDSC's and will continue into 2015

----------------------------------------
[Myeloid-derived Gr-1? CD11b? suppressor cells are involved in immunoregulation of experimental autoimmune encephalomyelitis].

[Article in Chinese]

Wu F1, Dang D1, Guo J1, Li H1, Yang K2, Zhao D1, Guo P1, Li Z1.
Author information

1Department of Neurology, Tangdu Hospital, Xi'an 710038, China.
2Department of Immunology, School of Preclinical Medicine, Fourth Military Medical University, Xi'an 710032, China.

Abstract
OBJECTIVE:

To explore the change in the number and role of Gr-1? CD11b? myeloid-derived suppressor cells (MDSCs) in experimental autoimmune encephalomyelitis (EAE).

Aug 30, 2014

CONCLUSION:

EAE induces an expansion and aggregation of Gr-1? CD11b? MDSCs in spleens and spinal cords. These cells suppress T cell proliferation in vitro and are involved in the immunoregulation of EAE.

http://www.ncbi.nlm.nih.gov/pubmed/25108427

----------------------------------------------------

... in case you wanted to know, it means inflammation

http://en.wikipedia.org/wiki/Encephalomyelitis

.... and yes, inflammation is mandatory pre-cancer

http://scienceblog.cancerresearchuk.org/2013/02/01/feeling-the-heat-the-link-between-inflammation-and-cancer/

http://mcr.aacrjournals.org/content/4/4/221.full



"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y